Helen Chew

Title(s)Professor, Hematology and Oncology
SchoolSchool of Medicine
AddressCancer Ctr So, #3016
CA 95817
Phone916-734-3772
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023. J Natl Compr Canc Netw. 2023 06; 21(6):594-608. Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, Mortimer J, Patel SA, Pierce LJ, Rosenberger LH, Rugo HS, Schneider B, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Young JS, Yeung K, Dwyer MA, Kumar R. PMID: 37308117.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    2. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 06; 20(6):691-722. Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Isakoff SJ, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch M, Lyons J, Mortimer J, Patel SA, Pierce LJ, Rosenberger LH, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Wisinski KB, Young JS, Burns J, Kumar R. PMID: 35714673.
      View in: PubMed   Mentions: 198     Fields:    Translation:Humans
    3. A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer. Cancer Chemother Pharmacol. 2022 05; 89(5):721-735. Manzo J, Puhalla S, Pahuja S, Ding F, Lin Y, Appleman L, Tawbi H, Stoller R, Lee JJ, Diergaarde B, Kiesel BF, Yu J, Tan AR, Belani CP, Chew H, Garcia AA, Morgan RJ, Wahner Hendrickson AE, Visscher DW, Hurley RM, Kaufmann SH, Swisher EM, Oesterreich S, Katz T, Ji J, Zhang Y, Parchment RE, Chen A, Duan W, Giranda V, Shepherd SP, Ivy SP, Chu E, Beumer JH, ETCTN-8282 study team. PMID: 35435472; PMCID: PMC9116722.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    4. Planning for post-pandemic cancer care delivery: Recovery or opportunity for redesign? CA Cancer J Clin. 2021 01; 71(1):34-46. Cinar P, Bold R, Bosslet BA, Bota DA, Burgess D, Chew HK, Cohen JG, Elquza E, Gold KA, Kamiya E, Karlan BY, McKay RR, Patel SP, Ternavan K, Welborn J, Yamamoto M, Rugo HS. PMID: 32997807; PMCID: PMC7537198.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    5. Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307. J Natl Cancer Inst. 2020 07 01; 112(7):698-707. Gralow JR, Barlow WE, Paterson AHG, M'iao JL, Lew DL, Stopeck AT, Hayes DF, Hershman DL, Schubert MM, Clemons M, Van Poznak CH, Dees EC, Ingle JN, Falkson CI, Elias AD, Messino MJ, Margolis JH, Dakhil SR, Chew HK, Dammann KZ, Abrams JS, Livingston RB, Hortobagyi GN. PMID: 31693129; PMCID: PMC7357327.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    6. Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma. Clin Cancer Res. 2019 02 15; 25(4):1206-1215. Hausner SH, Bold RJ, Cheuy LY, Chew HK, Daly ME, Davis RA, Foster CC, Kim EJ, Sutcliffe JL. PMID: 30401687; PMCID: PMC6377828.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    7. Breast cancer-specific survival in patients with HER2-positive, node-negative T1a and T1b breast cancer. Cancer Treat Res Commun. 2018; 16:38-44. Parikh M, Galkin M, Brunson A, Keegan T, Chew HK. PMID: 31299001.
      View in: PubMed   Mentions: 3     Fields:    
    8. Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study. J Cancer Surviv. 2018 06; 12(3):388-397. Keegan THM, Kushi LH, Li Q, Brunson A, Chawla X, Chew HK, Malogolowkin M, Wun T. PMID: 29427203.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    9. The value of red blood cell distribution width in diagnosis of patients with colorectal cancer. Clin Chim Acta. 2018 Apr; 479:98-102. Yang D, Quan W, Wu J, Ji X, Dai Y, Xiao W, Chew H, Sun Z, Li D. PMID: 29407693.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    10. Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial. JAMA Oncol. 2017 Jul 01; 3(7):906-912. Hortobagyi GN, Van Poznak C, Harker WG, Gradishar WJ, Chew H, Dakhil SR, Haley BB, Sauter N, Mohanlal R, Zheng M, Lipton A. PMID: 28125763; PMCID: PMC5824238.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    11. Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083. Clin Cancer Res. 2017 Aug 01; 23(15):4066-4076. Somlo G, Frankel PH, Arun BK, Ma CX, Garcia AA, Cigler T, Cream LV, Harvey HA, Sparano JA, Nanda R, Chew HK, Moynihan TJ, Vahdat LT, Goetz MP, Beumer JH, Hurria A, Mortimer J, Piekarz R, Sand S, Herzog J, Van Tongeren LR, Ferry-Galow KV, Chen AP, Ruel C, Newman EM, Gandara DR, Weitzel JN. PMID: 28356425; PMCID: PMC5540749.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    12. Underutilization of gene expression profiling for early-stage breast cancer in California. Cancer Causes Control. 2016 06; 27(6):721-7. Cress RD, Chen YS, Morris CR, Chew H, Kizer KW. PMID: 27097910; PMCID: PMC4871729.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    13. Medical education: perils and progress in educating and assessing a new generation of learners. Am Soc Clin Oncol Educ Book. 2015; 33-9. Gilbert J, Chew H, Dewey C, Horn L. PMID: 25993139.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer. J Clin Oncol. 2015 Jan 01; 33(1):58-64. Budd GT, Barlow WE, Moore HC, Hobday TJ, Stewart JA, Isaacs C, Salim M, Cho JK, Rinn KJ, Albain KS, Chew HK, Burton GV, Moore TD, Srkalovic G, McGregor BA, Flaherty LE, Livingston RB, Lew DL, Gralow JR, Hortobagyi GN. PMID: 25422488; PMCID: PMC4268253.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    15. Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance). J Clin Oncol. 2014 Dec 10; 32(35):3959-66. Burstein HJ, Cirrincione CT, Barry WT, Chew HK, Tolaney SM, Lake DE, Ma C, Blackwell KL, Winer EP, Hudis CA. PMID: 25348000; PMCID: PMC4251959.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    16. Oncology fellows’ career plans, expectations, and well-being: do fellows know what they are getting into? J Clin Oncol. 2014 Sep 20; 32(27):2991-7. Shanafelt TD, Raymond M, Horn L, Moynihan T, Collichio F, Chew H, Kosty MP, Satele D, Sloan J, Gradishar WJ. PMID: 25049326; PMCID: PMC4876315.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    17. Lymphoma and venous thromboembolism: influence on mortality. Thromb Res. 2014 May; 133 Suppl 2:S23-8. Mahajan A, Wun T, Chew H, White RH. PMID: 24862141.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    18. Satisfaction with work-life balance and the career and retirement plans of US oncologists. J Clin Oncol. 2014 Apr 10; 32(11):1127-35. Shanafelt TD, Raymond M, Kosty M, Satele D, Horn L, Pippen J, Chu Q, Chew H, Clark WB, Hanley AE, Sloan J, Gradishar WJ. PMID: 24616305; PMCID: PMC4876331.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    19. Phase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer. Springerplus. 2014; 3:108. Chew HK, Schwartzberg L, Badarinath S, Rubin P, Shumaker G, Daugherty J, DeSilvio M, Mahoney J. PMID: 26034656; PMCID: PMC4447850.
      View in: PubMed   Mentions: 1  
    20. Burnout and career satisfaction among US oncologists. J Clin Oncol. 2014 Mar 01; 32(7):678-86. Shanafelt TD, Gradishar WJ, Kosty M, Satele D, Chew H, Horn L, Clark B, Hanley AE, Chu Q, Pippen J, Sloan J, Raymond M. PMID: 24470006; PMCID: PMC3927737.
      View in: PubMed   Mentions: 120     Fields:    Translation:Humans
    21. The potential role of radiation therapy to the primary site of disease in stage IV breast cancer presenting with synchronous metastasis. Clin Breast Cancer. 2014 Feb; 14(1):10-2. Mayadev J, Daly M, Chen A, Bold R, Chew H. PMID: 24183416.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer. Invest New Drugs. 2013 Dec; 31(6):1587-91. Ho C, Davies AM, Sangha RS, Lau D, Lara P, Chew HK, Beckett L, Mack PC, Riess JW, Gandara DR. PMID: 24013936; PMCID: PMC4562389.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    23. Richter's syndrome with aberrant CD2 and CD4 expression. J Clin Oncol. 2012 Sep 10; 30(26):e243-5. Barnhard S, Pai A, Chew HK, Song JY. PMID: 22649134.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    24. Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430. Oncologist. 2012; 17(2):179-87. Schott AF, Barlow WE, Albain KS, Chew HK, Wade JL, Lanier KS, Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN. PMID: 22267853; PMCID: PMC3286166.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    25. Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors. Ann Oncol. 2012 Apr; 23(4):1023-9. Chew HK, Somlo G, Mack PC, Gitlitz B, Gandour-Edwards R, Christensen S, Linden H, Solis LJ, Yang X, Davies AM. PMID: 21778300.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    26. High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics. 2011 Jan; 10(1):M110.002717. de Leoz ML, Young LJ, An HJ, Kronewitter SR, Kim J, Miyamoto S, Borowsky AD, Chew HK, Lebrilla CB. PMID: 21097542; PMCID: PMC3013453.
      View in: PubMed   Mentions: 144     Fields:    Translation:HumansAnimalsCells
    27. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Cancer. 2010 Jun 01; 116(11):2596-603. Sandhu R, Pan CX, Wun T, Harvey D, Zhou H, White RH, Chew HK. PMID: 20336780.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    28. Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J Clin Oncol. 2010 Apr 01; 28(10):1671-6. Lo SS, Mumby PB, Norton J, Rychlik K, Smerage J, Kash J, Chew HK, Gaynor ER, Hayes DF, Epstein A, Albain KS. PMID: 20065191.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    29. Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer. J Clin Oncol. 2009 May 01; 27(13):2163-9. Chew HK, Doroshow JH, Frankel P, Margolin KA, Somlo G, Lenz HJ, Gordon M, Zhang W, Yang D, Russell C, Spicer D, Synold T, Bayer R, Hantel A, Stiff PJ, Tetef ML, Gandara DR, Albain KS. PMID: 19307510; PMCID: PMC2674003.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    30. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood. 2009 Apr 23; 113(17):3911-7. Ku GH, White RH, Chew HK, Harvey DJ, Zhou H, Wun T. PMID: 19088376; PMCID: PMC2673120.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    31. Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data. Bioinformatics. 2009 Jan 15; 25(2):251-7. Barkauskas DA, An HJ, Kronewitter SR, de Leoz ML, Chew HK, de Vere White RW, Leiserowitz GS, Miyamoto S, Lebrilla CB, Rocke DM. PMID: 19073586; PMCID: PMC2639011.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    32. A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338. Clin Breast Cancer. 2008 Dec; 8(6):511-5. Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow J, Hortobagyi GN, Livingston R. PMID: 19073506; PMCID: PMC3510680.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    33. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol. 2008 Jul; 112(1):71-8. Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, Smith L. PMID: 18591310.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    34. Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapy. Cancer Genomics Proteomics. 2008 May-Aug; 5(3-4):151-60. Xiao GG, Zhou BS, Somlo G, Portnow J, Juhasz A, Un F, Chew H, Gandara D, Yen Y. PMID: 18820369.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    35. 25th Chemotherapy Foundation Symposium. Innovative Cancer Therapy for Tomorrow. 6-10 November 2007, New York, NY, USA. IDrugs. 2008 Feb; 11(2):90-3. Chew HK. PMID: 18240090.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost. 2008 Apr; 6(4):601-8. Chew HK, Davies AM, Wun T, Harvey D, Zhou H, White RH. PMID: 18208538.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    37. Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation. Oncogene. 2007 Sep 13; 26(42):6160-6. Jeng YM, Cai-Ng S, Li A, Furuta S, Chew H, Chen PL, Lee EY, Lee WH. PMID: 17420720.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    38. Venous thromboembolism in ovarian cancer. Gynecol Oncol. 2007 Jun; 105(3):784-90. Rodriguez AO, Wun T, Chew H, Zhou H, Harvey D, White RH. PMID: 17408726.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    39. Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623. J Clin Oncol. 2007 May 01; 25(13):1677-82. Moore HC, Green SJ, Gralow JR, Bearman SI, Lew D, Barlow WE, Hudis C, Wolff AC, Ingle JN, Chew HK, Elias AD, Livingston RB, Martino S, Southwest Oncology Group/Intergroup Study 9623. PMID: 17404368.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    40. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg. 2007 Apr; 106(4):601-8. Semrad TJ, O'Donnell R, Wun T, Chew H, Harvey D, Zhou H, White RH. PMID: 17432710.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    41. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol. 2007 Jan 01; 25(1):70-6. Chew HK, Wun T, Harvey DJ, Zhou H, White RH. PMID: 17194906.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    42. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk? Thromb Res. 2007; 120 Suppl 2:S29-40. White RH, Chew H, Wun T. PMID: 18023711.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    43. A serum glycomics approach to breast cancer biomarkers. Mol Cell Proteomics. 2007 Jan; 6(1):43-55. Kirmiz C, Li B, An HJ, Clowers BH, Chew HK, Lam KS, Ferrige A, Alecio R, Borowsky AD, Sulaimon S, Lebrilla CB, Miyamoto S. PMID: 16847285.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansAnimalsCells
    44. Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment. Oncol Rep. 2006 May; 15(5):1299-304. Juhasz A, Vassilakos A, Chew HK, Gandara D, Yen Y. PMID: 16596201.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    45. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol. 2006 Mar 01; 24(7):1112-8. Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH. PMID: 16505431.
      View in: PubMed   Mentions: 122     Fields:    Translation:Humans
    46. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006 Feb 27; 166(4):458-64. Chew HK, Wun T, Harvey D, Zhou H, White RH. PMID: 16505267.
      View in: PubMed   Mentions: 384     Fields:    Translation:Humans
    47. Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast cancer. Breast Cancer Res Treat. 2005 Dec; 94(3):205-11. Mohsin SK, Allred DC, Osborne CK, Cruz A, Otto P, Chew H, Clark GM, Elledge RM. PMID: 16267611.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    48. High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody. Clin Cancer Res. 2005 Aug 15; 11(16):5920-7. Richman CM, Denardo SJ, O'Donnell RT, Yuan A, Shen S, Goldstein DS, Tuscano JM, Wun T, Chew HK, Lara PN, Kukis DL, Natarajan A, Meares CF, Lamborn KR, DeNardo GL. PMID: 16115934.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCTClinical Trials
    49. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med. 2005 Aug 8-22; 165(15):1782-7. White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D, Wun T. PMID: 16087828.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    50. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004 Sep-Oct; 10(5):294-300. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN. PMID: 15530258.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    51. BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II. Oncogene. 2004 Jul 08; 23(31):5316-29. Cabart P, Chew HK, Murphy S. PMID: 15107825.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    52. Medical management of breast cancer: today and tomorrow. Cancer Biother Radiopharm. 2002 Apr; 17(2):137-49. Chew HK. PMID: 12030108.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Adjuvant therapy for breast cancer: who should get what? West J Med. 2001 Apr; 174(4):284-7. Chew HK. PMID: 11290691; PMCID: PMC1071360.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    54. Genetic evaluation of cancer: the importance of family history. Tex Med. 2001 Feb; 97(2):40-5. Chew HK. PMID: 11233057.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Emerging roles of BRCA1 in transcriptional regulation and DNA repair. J Cell Physiol. 1999 Dec; 181(3):385-92. Chen Y, Lee WH, Chew HK. PMID: 10528224.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    56. Biological functions of the BRCA1 protein. Breast Dis. 1998 Apr; 10(1-2):11-22. Lee WH, Chew HK, Farmer AA, Chen PL. PMID: 15687545.
      View in: PubMed   Mentions: 2     Fields: